# The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy

> **NCT06969586** · — · ENROLLING_BY_INVITATION · sponsor: **University Hospital Dubrava** · enrollment: 50 (estimated)

## Conditions studied

- Fuchs Endothelial Corneal Dystrophy
- Cataract
- Glaucoma

## Interventions

- **DRUG:** Netarsudil 0.02% Ophthalmic Solution
- **DRUG:** artificial tear substitute

## Key facts

- **NCT ID:** NCT06969586
- **Lead sponsor:** University Hospital Dubrava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06969586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06969586, "The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06969586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*